Lunai Bioworks Inc.LNAI

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$1.94
Market cap
$8.7M
P/E
—
Revenue (TTM)
—
Net income
-$128.3M
Dividend yield
—
1-year total return
-82.8%
Net margin
—
Revenue growth
—
Debt / equity
—

What Lunai Bioworks Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue——————
Net income-$11.4M-$26.7M-$113.4M-$39.7M-$88.4M-$178.0M
Free cash flow-$10.6M-$20.7M-$15.7M-$11.8M-$11.0M—

More on LNAI.

Figures from Lunai Bioworks Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.